Brazil Approves First Generic Version Of Sovaldi
Executive Summary
Brazil’s first generic version of Sovaldi for hepatitis C is approved.
You may also be interested in...
Brazil Prepares To Make Its Own Sovaldi As Regulator Opposes Patent Application
Brazil could soon be manufacturing its own generic version of Gilead’s Sovaldi if opposition to the company’s patent application is upheld by the patent office.
Latin American Countries Set Up Joint Procurement Mechanism
Mercosur bloc has been conducting joint negotiations on HCV drugs; cancer treatments may be next on the agenda.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.